Edition:
United Kingdom

Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Global Market

0.49USD
20 Jul 2018
Change (% chg)

$-0.03 (-4.90%)
Prev Close
$0.51
Open
$0.50
Day's High
$0.50
Day's Low
$0.40
Volume
468,853
Avg. Vol
87,572
52-wk High
$5.59
52-wk Low
$0.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.200
FY 2017 Dec '17 0.00 -0.182
Sep '17 0.00 -0.222
Jun '17 0.00 -0.259
Mar '17 0.00 -0.261
FY 2016 Dec '16 0.00 -0.181
Sep '16 0.00 -0.271
Jun '16 0.00 -0.293
Mar '16 0.00 -0.273
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 8.80
Quarter Ending Dec-18 4 0.00 0.00 0.00 13.70
Year Ending Dec-18 4 0.00 0.00 0.00 28.28
Year Ending Dec-19 4 10.62 29.74 0.00 96.95
Earnings (per share)
Quarter Ending Sep-18 4 -0.16 -0.14 -0.18 -0.29
Quarter Ending Dec-18 4 -0.14 -0.11 -0.16 -0.20
Year Ending Dec-18 4 -0.66 -0.65 -0.67 -0.93
Year Ending Dec-19 4 -0.79 -0.27 -1.17 0.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.33 32.76
P/E High - Last 5 Yrs. -- 298.33 45.44
P/E Low - Last 5 Yrs. -- 91.43 24.26
Beta 2.07 0.93 0.89
Price to Sales (TTM) -- 112.52 5.73
Price to Book (MRQ) 5.23 15.54 5.47
Price to Tangible Book (MRQ) 6.20 14.64 7.05
Price to Cash Flow (TTM) -- 72.59 23.29
% Owned Institutions 78.05 14.53 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.35 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.02 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 79.88 5.64
Sales - 5 Yr. Growth Rate -- 32.06 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 11.73 29.02 20.60
EPS (TTM) vs TTM 1 Yr. Ago 16.43 -- --
EPS - 5 Yr. Growth Rate -- 39.49 10.66
Capital Spending - 5 Yr. Growth Rate -- 39.97 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 3.37 5.50 3.03
LT Debt to Equity (MRQ) 27.06 34.92 12.51
Total Debt to Equity (MRQ) 47.59 36.72 16.84
Interest Coverage (TTM) -15.94 -101.16 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.68 54.37
Gross Margin - 5 Yr. Avg. -- 50.98 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -586.56 10.81
Operating Margin (TTM) -- -733.21 4.58
Operating Margin - 5 Yr. Avg. -- -608.15 6.23
Pre-Tax Margin (TTM) -- -707.36 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -611.67 6.67
Net Profit Margin (TTM) -- -708.75 1.73
Net Profit Margin - 5 Yr. Avg. -- -614.69 2.94
Effective Tax Rate (TTM) -- 23.23 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.56 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,025,841 860,394,083
Net Income/Employee (TTM) -1,471,947 3,117,868 101,209,433
Receivable Turnover (TTM) -- 20.74 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -46.27 0.27 11.14
Return on Assets - 5 Yr. Avg. -- 3.72 12.40
Return on Investment (TTM) -55.62 2.22 14.61
Return on Investment - 5 Yr. Avg. -- 2.89 16.14
Return on Equity (TTM) -67.67 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 3.83 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 26.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Agile Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.04%
# of Holders: 57
Total Shares Held: 26,728,674
3 Mo. Net Change: -839,326
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.